41 – 50 of 113
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Three-dimensional mapping of neurofibrillary tangle burden in the human medial temporal lobe
- Contribution to journal › Article
-
Mark
From iPS Cells to Rodents and Nonhuman Primates : Filling Gaps in Modeling Parkinson's Disease
- Contribution to journal › Article
-
Mark
The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease
- Contribution to journal › Article
-
Mark
Inhibition of copper transporter 1 prevents α-synuclein pathology and alleviates nigrostriatal degeneration in AAV-based mouse model of Parkinson's disease
- Contribution to journal › Article
-
Mark
Pathological drivers of neurodegeneration in suspected non-Alzheimer’s disease pathophysiology
- Contribution to journal › Article
-
Mark
Animal Models of Metabolic Disorders in the Study of Neurodegenerative Diseases : An Overview
- Contribution to journal › Scientific review
-
Mark
A stress syndrome prototype reflects type 3 diabetes and ischemic stroke risk : The SABPA study
- Contribution to journal › Article
-
Mark
Editorial : Regeneration and Brain Repair
- Contribution to journal › Debate/Note/Editorial
-
Mark
Impact of differential and time-dependent autophagy activation on therapeutic efficacy in a model of Huntington disease
- Contribution to journal › Article
-
Mark
Nrf2 activation and downstream effects : Focus on parkinson’s disease and brain angiotensin
- Contribution to journal › Scientific review
